MEDS FOR ALL –
Dec. 13, 2022 – The changes, which appear to have broad support across medical organizations and addiction advocacy groups, underscore how sharply the addiction treatment landscape has shifted in light of Covid.
They also reflect a growing recognition from Washington that many Americans experiencing opioid addiction lack access to addiction medications. While methadone and buprenorphine are both controlled substances, the emergency measures significantly increased their availability. For the first time, doctors could initiate treatment with buprenorphine via telehealth instead of an in-person visit.
